{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-323651","form_type":"8-K","ticker":"IKT","cik":"0001750149","company_name":"Inhibikase Therapeutics, Inc.","filed_at":"2026-07-29T20:05:43+00:00","discovered_at":"2026-07-29T20:07:00.561217+00:00","generated_at":"2026-07-29T20:07:45.410465+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Inhibikase Therapeutics exchanges 18M shares with RA Capital for pre-funded warrants","bullets":["RA Capital exchanged 18,030,000 common shares for pre-funded warrants with $0.001 exercise price.","Warrants are immediately exercisable, no expiration, with 9.99% beneficial ownership blocker (can increase to 19.99%).","Issued under Section 3(a)(9) exemption from registration; no new cash raised.","Exchange reduces outstanding shares but introduces potential dilution upon warrant exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-323651","json":"https://secwatch.observer/filing/0001193125-26-323651.json","markdown":"https://secwatch.observer/filing/0001193125-26-323651.md","text":"https://secwatch.observer/filing/0001193125-26-323651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750149/000119312526323651/0001193125-26-323651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750149/000119312526323651/d78217d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T20:07:45.410465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}